Innovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan
SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan.
- SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan.
- This ground-breaking initiative is set to synergise their complementary strengths to enhance various clinical trial aspects throughout Japan, including feasibility assessments, participant screening, and enrolment.
- Buzzreach CEO Mr Takateru Inokawa added: "We believe this partnership will positively impact clinical trials in Japan.
- These apps optimise clinical trial processes, from information dissemination to patient engagement, creating a more efficient and effective drug development process.